New Atlas2d
Move over, Starlink, there's a new satellite-to-cell service in town
Most people with cell phones might not ever experience what it feels like to suddenly find yourself in a dead zone. If you ...
Compass price target raised to $6 from $5.75 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Compass (COMP) to $6 from $5.75 and keeps an Equal Weight rating on the ...
Johnson & Johnson’s Strategic Acquisition of Intra-Cellular Therapies: Balancing Short-term Dilution with Long-term Growth Potential
Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Tim ...
Hold Rating on JNJ Amid Uncertainty over Intra-Cellular Therapies Acquisition Impact
Terence Flynn, an analyst from Morgan Stanley, maintained the Hold rating on Johnson & Johnson (JNJ – Research Report). The associated ...
What Johnson & Johnson Is Getting With The Acquisition Of Intra-Cellular Therapies
Johnson & Johnson acquires Intra-Cellular Therapies for $14.6 billion. The biggest driver was the rights Caplyta which has ...